Join to view full profile
6420 Rockledge DrSte 4200Bethesda, MD 20817
Phone+1 301-424-6231
Fax+1 301-294-4648
Dr. Wallmark is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1995 - 1998
University of North Carolina HospitalsResidency, Internal Medicine, 1992 - 1995
Drexel University College of MedicineClass of 1992
Certifications & Licensure
MD State Medical License 1998 - 2027
FL State Medical License 2018 - 2020
PA State Medical License 1995 - 1998
NC State Medical License 1992 - 1995
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Flatiron Health, Inc., 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2012, 2014, 2016-2017
Clinical Trials
- Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma Start of enrollment: 2013 Sep 12
- Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. Start of enrollment: 2014 Sep 11
Publications & Presentations
PubMed
- 156 citationsPembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 StudyRoger B. Cohen, Jean Pierre Delord, Toshihiko Doi, Sarina Anne Piha-Paul, Stephen V. Liu
American Journal of Clinical Oncology. 2018-11-01 - 227 citationsSafety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinomaBert H. O'Neil, John M. Wallmark, David Lorente, Elena Elez, Judith Raimbourg
Plos One. 2017-12-28 - 13 citationsScleromyxedema: successful treatment of cutaneous and neurologic symptoms.Nieves Ds, Nieves Ds, Bondi Ee, Wallmark J, Raps Ec
Cutis. 2000-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
